•
Jun 27, 2020

Waters Q2 2020 Earnings Report

Waters' Q2 2020 financial performance was affected by lower demand across all major geographies due to the COVID-19 pandemic, but results reflected better-than-anticipated market conditions and strong execution.

Key Takeaways

Waters Corporation reported Q2 2020 sales of $520 million, a 13% decrease compared to Q2 2019. GAAP EPS decreased to $1.98, while non-GAAP EPS decreased to $2.10. Strong free cash flow of $175 million was reported for the quarter.

Sales of $520 million declined 13% as reported and 12% in constant currency

GAAP EPS of $1.98; non-GAAP EPS of $2.10, a 2% decrease from prior year

Cost savings plan of $100 million on track for the year

Strong free cash flow of $175 million for the quarter

Total Revenue
$520M
Previous year: $599M
-13.2%
EPS
$2.1
Previous year: $2.14
-1.9%
Pharma Market Sales
-11%
Industrial Market Sales
-14%
Academic & Gov Sales
-22%
Gross Profit
$307M
Previous year: $350M
-12.2%
Cash and Equivalents
$339M
Previous year: $588M
-42.3%
Free Cash Flow
$175M
Total Assets
$2.65B
Previous year: $2.82B
-6.2%

Waters

Waters

Waters Revenue by Geographic Location

Forward Guidance

The company is well-positioned to leverage its strong new product pipeline and is investing to take advantage of growth opportunities as demand normalizes.

Revenue & Expenses

Visualization of income flow from segment revenue to net income